SCHEMBL30852271

SCHEMBL30852271

[2H]C([2H])([2H])CCCCCc1cc(OC)c(CC(N)CC)cc1OC

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.64
TAAR1 Q96RJ0 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27002111 0.92 HTR2A (0.76) HTR2ATAAR1
SCHEMBL30852265 0.92 HTR2A (0.76) HTR2ATAAR1
SCHEMBL30852303 0.92 HTR2A (0.76) HTR2ATAAR1
Hydrochloric Acid SCHEMBL30852254 0.90 HTR2A (0.74) HTR2ATAAR1
SCHEMBL26612118 0.90 HTR2A (0.73) HTR2ATAAR1
SCHEMBL11739316 0.86 HTR2A (0.66) HTR2ATAAR1
SCHEMBL27002125 0.83 HTR2A (0.59) HTR2ATAAR1
SCHEMBL27002140 0.83 HTR2A (0.59) HTR2ATAAR1
SCHEMBL30730989 0.82 HTR2A (0.56) HTR2ATAAR1
SCHEMBL11736573 0.82 HTR2A (0.56) HTR2ATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024059090-A1 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2024-03-21 WO disclosed
WO-2024059017-A2 PHENALKYLAMINES AND METHODS OF MAKING AND USING THE SAME GILGAMESH PHARMACEUTICALS, INC. (US) 2024-03-21 WO disclosed